Research map: Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal)

Back to the article

Papers in this map

  1. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2007 · 10808 citations · Cited by this paper
  2. Cerebrospinal fluid hemolysis precedes secondary brain injury after aneurysmal subarachnoid hemorrhage · Raphael M. Buzzi · 2026 · Cites this paper
  3. Steroids or immunoglobulin for CIDP first-line treatment: why not both? · 2026 · Related
  4. Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies · Mervyn D. I. Vergouwen · 2010 · 1619 citations · Cited by this paper
  5. Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data · 2026 · Related
  6. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association · Brian Lim Hoh · 2023 · 1019 citations · Cited by this paper
  7. Diagnostic performance of machine learning models versus established risk stratification for intracranial aneurysm rupture: a systematic review and bivariate meta-analysis · 2026 · Related
  8. Delayed neurological deterioration after subarachnoid haemorrhage · Robert Loch Macdonald · 2013 · 917 citations · Cited by this paper
  9. Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study · 2026 · Related
  10. Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities · Karen Deborah Davis · 2020 · 514 citations · Cited by this paper
  11. Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy? · 2026 · Related
  12. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm · Matthew J. Rowland · 2012 · 363 citations · Cited by this paper
  13. DNA methylation profiling in central nervous system tumours · 2026 · Related
  14. The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement · Herbert Fried · 2016 · 351 citations · Cited by this paper
  15. Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study · 2026 · Related
  16. Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review · William Dodd · 2021 · 321 citations · Cited by this paper
  17. Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study · 2026 · Related
  18. Biomarker Discovery and Validation: Statistical Considerations · Fang‐Shu Ou · 2021 · 260 citations · Cited by this paper
  19. Visuospatial working memory in Huntington’s disease: behavioural and structural brain correlates · 2026 · Related
  20. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland · Aimun A. B. Jamjoom · 2017 · 129 citations · Cited by this paper
  21. Physical activity decreases the likelihood of peripheral neuropathy in persons with diabetes · 2026 · Related
  22. Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm · Michael Hugelshofer · 2019 · 84 citations · Cited by this paper
  23. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin · Patrick Garland · 2020 · 63 citations · Cited by this paper
  24. Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury · Kevin Akeret · 2021 · 63 citations · Cited by this paper
  25. Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage · Ian Galea · 2022 · 60 citations · Cited by this paper
  26. Spatial transcriptome analysis defines heme as a hemopexin-targetable inflammatoxin in the brain · Raphael M. Buzzi · 2021 · 36 citations · Cited by this paper
  27. Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation · Ian Galea · 2023 · 36 citations · Cited by this paper
  28. Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics · Raphael M. Buzzi · 2021 · 14 citations · Cited by this paper
  29. Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep · Bart R. Thomson · 2024 · 12 citations · Cited by this paper
  30. The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury · Kevin Akeret · 2022 · 11 citations · Cited by this paper
  31. Clinical severity of aneurysmal subarachnoid hemorrhage over time: systematic review · Manou Overstijns · 2024 · 11 citations · Cited by this paper
  32. Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage · Hannah Warming · 2023 · 10 citations · Cited by this paper
  33. Clinical potential of automated convolutional neural network-based hematoma volumetry after aneurysmal subarachnoid hemorrhage · Bart R. Thomson · 2023 · 9 citations · Cited by this paper
  34. Haptoglobin and Hemopexin Redirect Heme-Driven Oxidative Stress and Neurotoxicity in Organotypic Brain Slices · Anna-Lea Stalder · 2025 · 7 citations · Cited by this paper
  35. OxyHbMeter—a novel bedside medical device for monitoring cell-free hemoglobin in the cerebrospinal fluid—proof of principle · Nikolaos Tachatos · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)